Current cancer tests are remarkably antiquated. They are mostly invasive and not individualized. All current cancer testing and treatment is impersonal and non-specific. The testing is almost 99% surgical biopsies which must be read by a pathologist and the treatment is alway either surgery, chemo, immunotherapy or radiation. Its high time there was something individualized, personal, specific, systemic, and natural, that are specific for each individual based on your unique genetics and your immunological strengths and weakness. And the diagnosis should be a non-surgical, non-invasive test that can be acquidred via a simple blood test.
Finally, thanks to Dr. Ioannis Papasotiriou, MD, PhD, CEO and medical director of RGCC SA- Research Genetic Cancer Centre SA (www.rgcc-genlab.com) in Greece, such a test and such personalized Cancer, Virus and Lyme Disease testingand therapies are nowe available. Dr. Papasotiriou’s specialty in molecular oncology and cancer genetics has lead him to the development of innovative methods of cancer gene and molecular targeted therapies derived from non-invasive, non-surgical “liquid Biopsies.”